Allergosan ® oral solution is prescribed for adults and children over 12 years of age to relieve symptoms associated with:
Active ingredient: desloratadine.
1 ml of oral solution contains desloratadine 0.5 mg.
Excipients: propylene glycol; sodium; citric acid monohydrate, Trilon B; sorbitol solution that does not crystallize (E 420) sucrose; hypromellose; cherry flavor; purified water.
Hypersensitivity to the active substance or to any excipient of the preparation or to loratadine.
Use internally, regardless of food intake.
Adults and children over 12 years old, 10 ml (5 mg desloratadine) 1 time per day.
Therapy for intermittent allergic rhinitis (the presence of symptoms less than 4 days a week or less than 4 weeks) should be carried out taking into account the history data: stop after the disappearance of symptoms and restore after their recurrence.
For persistent allergic rhinitis (symptoms of more than 4 days a week or more than 4 weeks), treatment should be continued during the entire period of exposure to the allergen.
Pregnant
Desloratadine has not been shown to be teratogenic in animal studies. The safety of using the preparation during pregnancy has not been established, therefore, the use of desloratadine during this period is not recommended.
Desloratadine passes into breast milk, so its use in women who are breastfeeding is not recommended.
Children
Most cases of rhinitis in children under 2 years of age are infectious and there is no evidence to support treatment of infectious rhinitis with desloratadine.
Drivers
According to clinical studies, desloratadine has no or very little effect on the ability to drive and operate machinery.
In case of overdose, adverse reactions are similar to those observed at therapeutic doses, but the manifestations may be stronger.
In case of an overdose, apply standard measures to remove the non-adsorbed active substance, apply symptomatic treatment.
When using desloratadine at a dose of up to 45 mg (which is 9 times higher than the recommended ones), no clinically significant effects were observed in clinical studies in adults and adolescents.
Desloratadine is not removed by hemodialysis, and the possibility of its removal by peritoneal dialysis has not been established.
In clinical trials for indications, including allergic rhinitis and chronic idiopathic urticaria, adverse effects on desloratadine were reported 3% more frequently in patients receiving the recommended dose of 5 mg per day than in patients receiving placebo.
The most common adverse reactions reported were fatigue (1.2%), dry mouth (0.8%), and headache (0.6%) compared to placebo.
Clinically significant changes in the concentration of desloratadine in the blood plasma were not found after repeated use with ketoconazole, erythromycin, azithromycin, fluoxetine, cimetidine. Due to the fact that the enzyme responsible for the metabolism of desloratadine has not been established, interactions with other preparations cannot be completely ruled out.
Keep out of the reach of children.
Store in original packaging to protect from light.
This medicinal product does not require special temperature storage conditions.
Expiration date: 2 years.
The shelf life after opening the bottle is 3 months.
There are no reviews for this product.